Market Tracker

08/21 3:59pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.60
Real-Time Quote
 -0.25 / -2.82%
Today’s Change
5.84
Today|||52-Week Range
11.47
+14.06%
Year-to-Date

Today’s Trading

Previous close8.85
Today’s open8.95
Day’s range8.56 - 9.01
Volume299,259
Average volume (3 months)459,325
Market cap$379.9M
Dividend yield--
Data as of 3:44pm ET, 08/21/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+95.03%
Earnings growth (next 5 years)--
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book10.57

Competitors

 Today’s
change
Today’s
% change
NWBONorthwest Biotherape...-0.20-3.15%
DVAXDynavax Technologies...-0.01-0.70%
AMPEAmpio Pharmaceutical...-1.80-24.20%
TKMRTekmira Pharmaceutic...+0.61+3.44%
Data as of 3:58pm ET, 08/21/2014

Financials

Last reporting dateAugust 11, 2014
EPS forecast (this quarter)$0.05
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts